Drug Patents owned by Nexus Pharms
1. List of Emerphed drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11090278 | NEXUS PHARMS | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
May, 2040
(16 years from now) | |
| US11241400 | NEXUS PHARMS | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
May, 2040
(16 years from now) | |
| US11464752 | NEXUS PHARMS | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
May, 2040
(16 years from now) | |
| US11478436 | NEXUS PHARMS | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
May, 2040
(16 years from now) | |
| US11571398 | NEXUS PHARMS | NA |
May, 2040
(16 years from now) | |
Do you want to check out EMERPHED patents from before 2022?
Drugs and Companies using EPHEDRINE SULFATE ingredient
Market Authorisation Date: 17 April, 2020
Treatment: Use of ephedrine sulfate for treating hypotension
Dosage: SOLUTION;INTRAVENOUS
How can I launch a generic of EMERPHED before it's patent expiration?
More Information on Dosage
EMERPHED family patents
7
United States
1
Korea, Republic of
1
China
1
Israel
1
Canada
1
Japan
1
Australia
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic